Developer docs
API playgroundTry for free, no card

Search company profiles

Poriferous

Full company profile

uuid000gg1u

Namestring
Poriferous
Legal namestring
Poriferous, LLC
Websiteurl
poriferous.com
Company typeenum
Private
Founded yearint
2012
Descriptiontext

Poriferous, LLC (operating as SU-POR) is a privately held medical device manufacturer founded in 2012 and headquartered in Newnan, Georgia. The company designs, manufactures, and distributes porous polyethylene surgical implants for craniomaxillofacial reconstruction and augmentation, organized into four product categories: cranial, orbital, facial, and patient-specific implants, with approximately 20+ sub-product SKUs addressing defects ranging from burr hole covers to full cranial domes. The core SU-POR technology is a 100% porous polyethylene material with an interconnecting, omnidirectional pore structure that promotes fibrovascular tissue integration, supports long-term implant stability, and is MR Safe, non-pyrogenic, and EO sterilized. Patient-specific implants are designed from CT scans via a digital workflow with surgeon design approval and shipped as sterile kits in as little as 8 business days. The company cites 30+ years of underlying research, 1,000+ clinical publications, and 250,000+ successful procedures with a less than 0.5% reported infection rate.

Poriferous monetizes through one-time sales of standardized catalog implants and custom patient-specific devices to surgeons and hospitals, with revenue generated via direct sales in the US and an international distribution partner network abroad. Regulatory access is a foundational asset: the company holds FDA 510(k) clearance, CE 0297 marking, MDSAP ISO 13485:2016, EN ISO 13485:2016 DAkkS, and GMP ANVISA Brazil certification, enabling commercial sales across the US, EU, Brazil, and other MDSAP-participating jurisdictions. Go-to-market combines direct enterprise field sales targeting craniomaxillofacial, plastic, and oral/maxillofacial surgeons, paired with channel partners in international markets, supported by clinical evidence libraries, surgeon testimonials, and digital product catalogs. The company operates as a founder-owned LLC (Aaron Noble, founder), with 11-50 employees and no disclosed external funding rounds, M&A activity, or public reporting.

Short descriptiontext

Poriferous manufactures SU-POR porous polyethylene surgical implants for craniomaxillofacial reconstruction, including cranial, orbital, facial, and patient-specific implants. The privately held Georgia-based company sells directly to surgeons and hospitals in the US and through international distribution partners, holding FDA, CE, and ANVISA regulatory clearances.

Operating statusenum
Operating
Ownership categoryenum
Headcount rangeband
11–50
akta.pro rankint
HeadquartersNewnan, United States
HQ citystring
Newnan
HQ countrystring
United States
HQ regionstring
North America
Markets served

Serves global market

Offices1 record

Each record includes

City, Country, Type, Description, Source

Keyword5 values
craniomaxillofacial implants, porous polyethylene implants, surgical implant manufacturing, patient-specific cranial implants, medical device manufacturer
Industry3 codes
1Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts)
CodeHLAHAEADPrimaryYes
23D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial)
CodeHLAHAEAJPrimaryNo
3Medical & Dental 3D Printing Services (patient-specific devices, dental labs)
CodeIMAAADAGPrimaryNo
NAICS code1 code
  • Surgical Appliance and Supplies Manufacturing339113
SIC code2 codes
  • Orthopedic, Prosthetic & Surgical Appliances & Supplies3842
  • Surgical & Medical Instruments & Apparatus3841
Product category
Craniomaxillofacial Surgical Implants
GTM motion2 records

Each record includes

Type, Description, Source

Revenue model2 records
1Standard Surgical Implants
TypeOne Time License
Description

Poriferous generates revenue through the sale of pre-manufactured porous polyethylene implants for cranial, orbital, and facial reconstruction. Products are sold to surgeons and hospitals as one-time surgical implants.

2Patient-Specific Custom Implants
TypeOne Time License
Description

Custom-designed implants based on patient CT scans, manufactured to individual anatomical specifications. Ordered through a digital workflow with design approval process and shipped as a complete sterile kit.

poriferous.com
Marketing channels5 records

Each record includes

Title, Type, Stage, Description, Source

Distribution channels2 records

Each record includes

Title, Type, Scope, Target buyer, Description, Source

Cost components6 values
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others
GTM typeB2B
B2B
Offering typeHardware or Manufacturing
Hardware or Manufacturing
Brand1 record
1SU-POR
Description

Porous polyethylene surgical implants brand for craniomaxillofacial reconstruction including cranial, orbital, facial, and patient-specific implants.

poriferous.com
Core offering1 text field

Poriferous designs, manufactures, and sells SU-POR® porous polyethylene surgical implants for craniomaxillofacial reconstruction and augmentation. The product line includes pre-manufactured cranial, orbital, and facial implant shapes as well as custom patient-specific implants designed from individual CT scans. Implants are sold to surgeons, hospitals, and international distribution partners for use in trauma, tumor resection, congenital defect, and cosmetic reconstruction procedures.

Differentiator
Functional benefit
Problem solved
Quantifiable outcome1 of 4 values shown
  • Infection rate of less than 0.5%
+3 more records
Product overview1 text field

Poriferous is a medical device company that manufactures and sells SU-POR® porous polyethylene implants for craniomaxillofacial reconstruction and augmentation. The product portfolio consists of four main product categories: Cranial Implants (including Cranial Dome, Cranial Hemisphere, Cranial Flex Grid, Temporal Flex Grid, Flex Sheet, Osteotomy Gap Filler, Pterional Implant, Orbito-zygomatic, Posterior Fossa Plate, Occipital Implant, Retrosigmoid, Mastoid, Sellar Floor, Burr Hole Cover, and universal Sheet/Block/Membrane Sheet variants), Orbital Implants (Sphere, Cor-Tec Sphere, Quadro-Port Tunnel Orbital Sphere, Conical Orbital, Channel Sheet, Single Channel Sheet, Fan Plate, Orbital Floor Plate, Floor-Tec Composite Orbital Floor, 3D Orbital Floor, Enophthalmos Wedge, and various Rim/Alteration implants), Facial Implants (ear, nasal, malar, midface, chin, and mandible implants), and Patient-Specific Implants (custom-designed to match individual patient anatomy). All products are made from biocompatible porous polyethylene with interconnecting pore structures that promote fibrovascular tissue integration.

Product and service4 records
1SU-POR® Surgical Implants (Core Product Line)
CategoryCraniomaxillofacial Surgical Implants
Description

Biocompatible porous polyethylene implants with interconnecting, omnidirectional pore structure that promotes fibrovascular ingrowth and tissue integration, used for craniomaxillofacial reconstruction and augmentation. Sold to surgeons and hospitals worldwide under the SU-POR brand.

2Cranial Implants
CategoryCranial Surgical Implants
Description

Porous polyethylene cranial implants for cranioplasty and reconstruction following trauma, tumor resection, congenital defects, and revision of prior implants. Supports tissue integration, provides long-term stability, and allows surgeons to shape or customize implants based on defect requirements.

3Orbital Implants
CategoryOrbital Surgical Implants
Description

Porous polyethylene orbital implants designed to restore orbital volume, support soft tissue, and enhance structural integrity following trauma, congenital defects, or tumor removal. Includes sphere, fan plate, channel sheet, and 3D orbital floor variants.

4Facial Implants
CategoryFacial Surgical Implants
Description

Porous polyethylene facial implants designed to provide enhanced definition, volume, and structural support for both cosmetic and reconstructive applications, including auricular reconstruction for microtia patients, nasal, malar, midface, chin, and mandible augmentation.

Scale indicator4 records

Each record includes

Type, Value, Description, Source

Recent move5 records

Each record includes

Date, Type, Title, Description, Source

Expansion highlight5 records

Each record includes

Type, Description

Peers10 records
TypeBroad incumbent
Description

Global diversified medical device company with a significant Craniomaxillofacial (CMF) business including cranial, facial, and orbital reconstruction implants. Directly comparable to Poriferous as a competitor in CMF porous and titanium implant categories, but operates at vastly greater scale with broader neurosurgical and orthopedic portfolios.

TypeBroad incumbent
Description

Major orthopedic and CMF implant manufacturer offering cranial, facial, and reconstructive solutions. Overlaps with Poriferous in CMF reconstruction though it is significantly larger and more diversified across joint reconstruction and dental.

TypeBroad incumbent
Description

Large orthopedic and neurosurgery division of J&J with a CMF and cranial reconstruction portfolio. Comparable as a broader incumbent offering overlapping cranial and facial implant products alongside a much wider trauma and spine catalog.

TypeDirect peer
Description

Specialty CMF implant manufacturer offering porous polyethylene cranial and facial implants, directly competing with Poriferous in the same product category and clinical use cases.

TypeDirect peer
Description

Specialized neurosurgery and CMF implant manufacturer offering cranial reconstruction, dural repair, and tissue regeneration products. Closely comparable niche focus on cranial and neurosurgical implants, making it one of the most direct competitive analogues to Poriferous.

TypeDirect peer
Description

German-headquartered specialist in craniomaxillofacial surgery implants, distractors, and surgical instruments. Directly comparable to Poriferous with a similar CMF-focused product portfolio and global distribution model.

TypeEmerging player
Description

Emerging player in 3D-printed titanium spinal and CMF implants, representing the technological shift toward patient-specific 3D-printed metallic implants that competes with porous polyethylene offerings like Poriferous.

TypeOthers
Description

Orthobiologics and specialty implant company serving CMF and orthopedic reconstruction. Comparable as an adjacent specialty implant supplier, though it focuses more on biologics than pure porous polyethylene implants.

TypeEmerging player
Description

Specialty CMF and neurosurgery implant company offering cranial and small-bone reconstruction products. Comparable emerging competitor in niche CMF reconstruction with overlapping customer base among craniofacial and oculoplastic surgeons.

TypeBroad incumbent
Description

Global medtech incumbent with neurosurgery and cranial reconstruction product lines (e.g., TiMesh, Cranial Reconstruction). Comparable as a competing supplier in hospital CMF tenders but with vastly broader portfolio and sales footprint.

Market position
Strengths5 records

Each record includes

Headline, Details, Source

Weaknesses5 records

Each record includes

Headline, Details, Source

Competitive moat4 records

Each record includes

Type, Details

Key risks7 records

Each record includes

Headline, Details, Source

Key highlights7 records

Each record includes

Headline, Details, Source

Customer concentration

Classification, Details

Named customers6 records

Each record includes

Name, Industry, Type, Use case, Source, UUID

Segment3 records

Each record includes

Title, Type, Primary, Description, Pain point addressed, Use case, Source

Ideal customer profile3 records

Each record includes

Profile, Firmographic size, Sales motion, Sales cycle length, Buying structure, Purchase trigger, Buyer persona, Geography, Industry vertical, Primary use case, Description, Pain points, Evidence proof points, Target buyer

Technology focused
No
API detail
Has APIbool
No

Docs URL, Description

AI maturity
App detail

Has app

Feature4 records

Each record includes

Title, Differentiator, Description, Source

Core technology
Revenue estimate
Valuation estimate
Number of profiles
Profiles1 record

Each record includes

Name, Designation, Designation category, Overview, Profile commentary, Source

No data
Compliance5 records

Each record includes

Name, Class, Description

Funding overview

Funding stage, Last funding date, Total funding USD

Funding rounds

Each record includes

Round, Amount USD, Date, Pre money valuation, Total investors, Investors, News

Investors

Each record includes

Name, Type, Date of entry, Rounds participated, Website

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Each record includes

Name, Acquisition type, Announced date, Completed date, Status, Website, News

Investment

Each record includes

Name, Round, Announced date, Lead investor, Website, News

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Poriferous

Craniomaxillofacial Surgical Implantsporiferous.com

Poriferous manufactures SU-POR porous polyethylene surgical implants for craniomaxillofacial reconstruction, including cranial, orbital, facial, and patient-specific implants. The privately held Georgia-based company sells directly to surgeons and hospitals in the US and through international distribution partners, holding FDA, CE, and ANVISA regulatory clearances.

What Poriferous does

Poriferous, LLC (operating as SU-POR) is a privately held medical device manufacturer founded in 2012 and headquartered in Newnan, Georgia. The company designs, manufactures, and distributes porous polyethylene surgical implants for craniomaxillofacial reconstruction and augmentation, organized into four product categories: cranial, orbital, facial, and patient-specific implants, with approximately 20+ sub-product SKUs addressing defects ranging from burr hole covers to full cranial domes. The core SU-POR technology is a 100% porous polyethylene material with an interconnecting, omnidirectional pore structure that promotes fibrovascular tissue integration, supports long-term implant stability, and is MR Safe, non-pyrogenic, and EO sterilized. Patient-specific implants are designed from CT scans via a digital workflow with surgeon design approval and shipped as sterile kits in as little as 8 business days. The company cites 30+ years of underlying research, 1,000+ clinical publications, and 250,000+ successful procedures with a less than 0.5% reported infection rate.

Poriferous monetizes through one-time sales of standardized catalog implants and custom patient-specific devices to surgeons and hospitals, with revenue generated via direct sales in the US and an international distribution partner network abroad. Regulatory access is a foundational asset: the company holds FDA 510(k) clearance, CE 0297 marking, MDSAP ISO 13485:2016, EN ISO 13485:2016 DAkkS, and GMP ANVISA Brazil certification, enabling commercial sales across the US, EU, Brazil, and other MDSAP-participating jurisdictions. Go-to-market combines direct enterprise field sales targeting craniomaxillofacial, plastic, and oral/maxillofacial surgeons, paired with channel partners in international markets, supported by clinical evidence libraries, surgeon testimonials, and digital product catalogs. The company operates as a founder-owned LLC (Aaron Noble, founder), with 11-50 employees and no disclosed external funding rounds, M&A activity, or public reporting.

Poriferous firmographics

Firmographics
Name
Poriferous
Legal name
Poriferous, LLC
Website
https://poriferous.com
Company type
Private
Founded year
2012
Operating status
Operating
Headcount range
11–50 employees
Short description
Poriferous manufactures SU-POR porous polyethylene surgical implants for craniomaxillofacial reconstruction, including cranial, orbital, facial, and patient-specific implants. The privately held Georgia-based company sells directly to surgeons and hospitals in the US and through international distribution partners, holding FDA, CE, and ANVISA regulatory clearances.
Ownership category
akta.pro rank

Poriferous industry classification

Industry
Product category
Craniomaxillofacial Surgical Implants
NAICS
Surgical Appliance and Supplies Manufacturing (339113)
SIC
Orthopedic, Prosthetic & Surgical Appliances & Supplies (3842), Surgical & Medical Instruments & Apparatus (3841)
akta.pro primary industry
Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts) (HLAHAEAD)
akta.pro secondary industries
3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial) (HLAHAEAJ), Medical & Dental 3D Printing Services (patient-specific devices, dental labs) (IMAAADAG)

Keywords

  • Craniomaxillofacial implants
  • Porous polyethylene implants
  • Surgical implant manufacturing
  • Patient-specific cranial implants
  • Medical device manufacturer

Where Poriferous is headquartered

Location

Headquarters

HQ city
Newnan
HQ country
United States
HQ region
North America

Offices1 record

Markets served

Poriferous business model

Business model
GTM type
B2B
Offering type
Hardware or Manufacturing
Cost components
Supply Chain, Operations, Personnel, Technology or R&D, Marketing or Sales, Others

Revenue model

  1. Standard Surgical Implants: Poriferous generates revenue through the sale of pre-manufactured porous polyethylene implants for cranial, orbital, and facial reconstruction. Products are sold to surgeons and hospitals as one-time surgical implants.
  2. Patient-Specific Custom Implants: Custom-designed implants based on patient CT scans, manufactured to individual anatomical specifications. Ordered through a digital workflow with design approval process and shipped as a complete sterile kit.

Go-to-market motion2 records

Distribution channels2 records

Marketing channels5 records

Poriferous product offering

Product offering

Core offering

Poriferous designs, manufactures, and sells SU-POR® porous polyethylene surgical implants for craniomaxillofacial reconstruction and augmentation. The product line includes pre-manufactured cranial, orbital, and facial implant shapes as well as custom patient-specific implants designed from individual CT scans. Implants are sold to surgeons, hospitals, and international distribution partners for use in trauma, tumor resection, congenital defect, and cosmetic reconstruction procedures.

Product overview

Poriferous is a medical device company that manufactures and sells SU-POR® porous polyethylene implants for craniomaxillofacial reconstruction and augmentation. The product portfolio consists of four main product categories: Cranial Implants (including Cranial Dome, Cranial Hemisphere, Cranial Flex Grid, Temporal Flex Grid, Flex Sheet, Osteotomy Gap Filler, Pterional Implant, Orbito-zygomatic, Posterior Fossa Plate, Occipital Implant, Retrosigmoid, Mastoid, Sellar Floor, Burr Hole Cover, and universal Sheet/Block/Membrane Sheet variants), Orbital Implants (Sphere, Cor-Tec Sphere, Quadro-Port Tunnel Orbital Sphere, Conical Orbital, Channel Sheet, Single Channel Sheet, Fan Plate, Orbital Floor Plate, Floor-Tec Composite Orbital Floor, 3D Orbital Floor, Enophthalmos Wedge, and various Rim/Alteration implants), Facial Implants (ear, nasal, malar, midface, chin, and mandible implants), and Patient-Specific Implants (custom-designed to match individual patient anatomy). All products are made from biocompatible porous polyethylene with interconnecting pore structures that promote fibrovascular tissue integration.

Differentiator

Problem solved

Functional benefit

Brands

  • SU-POR: Porous polyethylene surgical implants brand for craniomaxillofacial reconstruction including cranial, orbital, facial, and patient-specific implants.

Products and services

  • SU-POR® Surgical Implants (Core Product Line) Biocompatible porous polyethylene implants with interconnecting, omnidirectional pore structure that promotes fibrovascular ingrowth and tissue integration, used for craniomaxillofacial reconstruction and augmentation. Sold to surgeons and hospitals worldwide under the SU-POR brand.
  • Cranial Implants Porous polyethylene cranial implants for cranioplasty and reconstruction following trauma, tumor resection, congenital defects, and revision of prior implants. Supports tissue integration, provides long-term stability, and allows surgeons to shape or customize implants based on defect requirements.
  • Orbital Implants Porous polyethylene orbital implants designed to restore orbital volume, support soft tissue, and enhance structural integrity following trauma, congenital defects, or tumor removal. Includes sphere, fan plate, channel sheet, and 3D orbital floor variants.
  • Facial Implants Porous polyethylene facial implants designed to provide enhanced definition, volume, and structural support for both cosmetic and reconstructive applications, including auricular reconstruction for microtia patients, nasal, malar, midface, chin, and mandible augmentation.

Quantifiable outcome

  • Infection rate of less than 0.5%
  • +3 more outcomes

Companies that use Poriferous

Customer profile

Named customers6 records

Segments3 records

Ideal customer profiles3 records

Poriferous technology and API

Technology

Technology focussed No

API detail

Has API
No
API docs
API detail

Core technology

AI maturity

App detail

Feature4 records

Poriferous partnerships and signals

Strategic signal

Scale indicators4 records

Recent moves5 records

Expansion highlights5 records

Poriferous competitors and assessment

Company assessment

Broad incumbents

  • Stryker: Global diversified medical device company with a significant Craniomaxillofacial (CMF) business including cranial, facial, and orbital reconstruction implants. Directly comparable to Poriferous as a competitor in CMF porous and titanium implant categories, but operates at vastly greater scale with broader neurosurgical and orthopedic portfolios.
  • Zimmer Biomet: Major orthopedic and CMF implant manufacturer offering cranial, facial, and reconstructive solutions. Overlaps with Poriferous in CMF reconstruction though it is significantly larger and more diversified across joint reconstruction and dental.
  • DePuy Synthes (Johnson & Johnson): Large orthopedic and neurosurgery division of J&J with a CMF and cranial reconstruction portfolio. Comparable as a broader incumbent offering overlapping cranial and facial implant products alongside a much wider trauma and spine catalog.
  • Medtronic: Global medtech incumbent with neurosurgery and cranial reconstruction product lines (e.g., TiMesh, Cranial Reconstruction). Comparable as a competing supplier in hospital CMF tenders but with vastly broader portfolio and sales footprint.

Direct peers

  • Matrix Surgical USA: Specialty CMF implant manufacturer offering porous polyethylene cranial and facial implants, directly competing with Poriferous in the same product category and clinical use cases.
  • Integra LifeSciences: Specialized neurosurgery and CMF implant manufacturer offering cranial reconstruction, dural repair, and tissue regeneration products. Closely comparable niche focus on cranial and neurosurgical implants, making it one of the most direct competitive analogues to Poriferous.
  • KLS Martin: German-headquartered specialist in craniomaxillofacial surgery implants, distractors, and surgical instruments. Directly comparable to Poriferous with a similar CMF-focused product portfolio and global distribution model.

Emerging players

  • Xenco Medical: Emerging player in 3D-printed titanium spinal and CMF implants, representing the technological shift toward patient-specific 3D-printed metallic implants that competes with porous polyethylene offerings like Poriferous.
  • OsteoMed (Colson Associates): Specialty CMF and neurosurgery implant company offering cranial and small-bone reconstruction products. Comparable emerging competitor in niche CMF reconstruction with overlapping customer base among craniofacial and oculoplastic surgeons.

Others

  • Bacterin International (now part of Xtant Medical): Orthobiologics and specialty implant company serving CMF and orthopedic reconstruction. Comparable as an adjacent specialty implant supplier, though it focuses more on biologics than pure porous polyethylene implants.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat4 records

Key risks7 records

Key highlights7 records

Customer concentration

Poriferous social profiles

Digital presence

Poriferous compliance and trust

Trust signal

Compliance5 records

Poriferous financial estimates

Financial estimate

Revenue estimate

Valuation estimate

Poriferous leadership team

Management profile

Number of profiles

Profiles1 record

Poriferous funding detail

Funding detail

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

Poriferous M&A and investment

M&A and investment

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Poriferous

What does Poriferous do?

Poriferous designs, manufactures, and sells SU-POR® porous polyethylene surgical implants for craniomaxillofacial reconstruction and augmentation. The product line includes pre-manufactured cranial, orbital, and facial implant shapes as well as custom patient-specific implants designed from individual CT scans. Implants are sold to surgeons, hospitals, and international distribution partners for use in trauma, tumor resection, congenital defect, and cosmetic reconstruction procedures.

Is Poriferous a public or private company?

Poriferous is a private company. It is classified as founder individual operated bootstrapped and is currently operating.

When was Poriferous founded?

Poriferous was founded in 2012. It employs 11 to 50 people.

Where is Poriferous based?

Poriferous is headquartered in Newnan, United States, in the North America region.

How does Poriferous make money?

Two revenue lines are on record. Standard Surgical Implants are the primary driver. The others are patient-Specific Custom Implants.

Who are Poriferous's main competitors?

Broad incumbents on record are Stryker, Zimmer Biomet, DePuy Synthes (Johnson & Johnson) and Medtronic. Direct peers are Matrix Surgical USA, Integra LifeSciences and KLS Martin. Emerging players are Xenco Medical and OsteoMed (Colson Associates). Bacterin International (now part of Xtant Medical) is listed as an others.

Does Poriferous have an API?

No public API is recorded for Poriferous.

What industry is Poriferous in?

Poriferous's product category is Craniomaxillofacial Surgical Implants. Its primary akta.pro industry code is HLAHAEAD, Neurosurgical Implants & Cranial/CMF (Cranial Plates, Dural Repair, Shunts), with a secondary code of HLAHAEAJ, 3D-Printed & Patient-Specific Implants (Custom Ortho/Spine/Cranial). Its NAICS code is 339113 and its SIC code is 3842.

Unlock the full company data

50 free credits on sign-up, no credit card required.

Contact sales
Live signals
Medical Device NetworkPoriferous’ DuraBloc technology secures US patentPoriferous, a porous polyethylene implant manufacturer, has received a patent from the US Patent and Trademark Office for its DuraBloc craniomaxillofacial implant technology. The technology features a dual-sided design combining a nonporous smooth underside with porous polyethylene on remaining sides, allowing fibrovascular ingrowth while reducing tissue adhesion for easier implant removal. The technology is available through Poriferous' Patient-Specific Implants programme and can be fabricated with a 50% lower flange profile for improved cosmetic outcomes.PR NewswirePoriferous, LLC Secures Patent for DuraBloc™ TechnologyPoriferous, LLC has been awarded U.S. Patent No. 12,653,677 for its DuraBloc™ technology by the USPTO, issued on June 16, 2026. The DuraBloc™ technology features a dual-sided design with a smooth, nonporous underside that reduces tissue adhesion while maintaining porous polyethylene structures, enabling 50% lower flange profile for better cosmetic fit and easier implant removal. This patent expands the company's proprietary technology portfolio for patient-specific craniomaxillofacial implants manufactured from SuᐧPor biocompatible porous polyethylene.MorningstarPoriferous, LLC Secures Patent for DuraBloc™ TechnologyPoriferous, LLC received U.S. Patent No. 12,653,677 for its DuraBloc™ technology on June 16, 2026. The patent covers a smooth, nonporous underside with porous polyethylene structures, enabling easier removal and a 50% lower flange profile. The technology is exclusive to Poriferous' Patient-Specific Implants program.PR.comPoriferous, LLC Announces Publication of U.S. Patent Application for Dura-Bloc™ TechnologyPoriferous, LLC announced that the USPTO has published patent application US-20230165682-A1 for their Dura-Bloc™ Patient Specific Cranial Implants technology. The Dura-Bloc™ technology enables one surface of an implant to serve as a tissue ingrowth surface while the opposite surface acts as a tissue ingrowth barrier, with average pore size varying across the implant thickness. This development expands Poriferous' portfolio of patented technologies and reinforces the company's position in craniomaxillofacial reconstruction solutions.